FINWIRES · TerminalLIVE
FINWIRES

Audinate Group Shares Marginally Lower After Making Three Additions to Dante Avio Install Adapter Products

By

Audinate Group (ASX:AD8) shares were marginally lower in recent Friday trade after it said in a Thursday statement it made three new additions to its Dante Avio Install adapter products, Dante Avio Install 4-Ch Analog Input, 4-Ch Analog Output, and 2-Ch In/2-Ch Out Analog adapters, all featuring dual switched Ethernet ports allowing up to four units to share a single network drop via daisy chaining.

The new models allow for higher channel density when connecting to amplifiers, line mixers, digital signal processors, and other analog installed audio visual equipment.

The adapters are launching with exclusive distribution through Midwich in the US, with units expected to ship in late June.

Related Articles

Asia

Dazhong Mining's Subsidiary to Borrow 250 Million Yuan; Shares Up 3%

Dazhong Mining's (SHE:001203) subsidiary, Anhui Jinrisheng Mining, agreed to borrow 250 million yuan from Bank of China's (SHA:601988, HKG:3988) Lu'an branch, according to a Shenzhen bourse filing on Friday.Dazhong Mining serves as the guarantor for the loan.The mining company's available guarantee balance for Jinrisheng Mining reduced to 1.20 billion yuan from 1.45 billion yuan.Dazhong's shares jumped 3% during the midday trade.

$HKG:3988$SHA:601988$SHE:001203
Asia

DL Holdings-Backed ARTi Raises $1.5 Million in Pre-A Funding Round

DL Holdings (HKG:1709) said C Capital AI agreed to invest $1.5 million in ARTi Holding through a pre-A funding round, according to a Thursday Hong Kong bourse filing.The investor will subscribe for 500 new Class B shares, implying a pre-money valuation of $30 million for the artificial intelligence investment research platform.Following the transaction, DL Holdings' stake in ARTi will be diluted to about 47.6% from 50%.

$HKG:1709
Asia

CF PharmTech Clears GMP Inspection for Suzhou Inhalation Drug Facility

CF PharmTech (HKG:2652) said its inhalation formulation production base in Suzhou passed a good manufacturing practice inspection conducted by the drug regulator of a member country of the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme, according to a Thursday Hong Kong bourse filing.The inspection covered the facility's production management and quality control systems, premises, equipment, data integrity, and computerized systems.Shares of the pharmaceutical firm were up over 1% in Friday morning trade.

$HKG:2652